cbdMD, Inc.YCBDNYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank84
5Y CAGR+23.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+23.2%/yr
Long-term compound
Percentile
P84
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 23.46% |
| Q3 2025 | -23.30% |
| Q2 2025 | 720.07% |
| Q1 2025 | -67.08% |
| Q4 2024 | -14.04% |
| Q3 2024 | -45.98% |
| Q2 2024 | -19.16% |
| Q1 2024 | -56.13% |
| Q4 2023 | -22.09% |
| Q3 2023 | -71.79% |
| Q2 2023 | -43.57% |
| Q1 2023 | -3.34% |
| Q4 2022 | -14.04% |
| Q3 2022 | -34.76% |
| Q2 2022 | -42.11% |
| Q1 2022 | -5.24% |
| Q4 2021 | -20.02% |
| Q3 2021 | 13.67% |
| Q2 2021 | 3.95% |
| Q1 2021 | -7.84% |
| Q4 2020 | 8.26% |
| Q3 2020 | -6.71% |
| Q2 2020 | -9.31% |
| Q1 2020 | 19.50% |
| Q4 2019 | 14.07% |
| Q3 2019 | 45.55% |
| Q2 2019 | 256.42% |
| Q1 2019 | -132.08% |
| Q4 2018 | 29.29% |
| Q3 2018 | -28.64% |
| Q2 2018 | 3.81% |
| Q1 2018 | 6.93% |
| Q4 2017 | 136.33% |
| Q3 2017 | -21.36% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 100.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |